CE Mark registration received for the PromarkerD Hub – a software tool used to calculate the risk...
CE Mark for predictive test for diabetic kidney disease
Proteomics International is proud to announce it has secured CE Mark registration for PromarkerD (MS) as an IVD medical device (in vitro diagnostic).
PromarkerD is the world-leading test for predicting the onset of diabetic kidney disease. PromarkerD was registered for use in the Europe Union (EU) as part of the company’s program of future asset registration.